An effective nanoparticles for drug delivery system

被引:3
作者
Gade, Jaya [1 ]
Jain, Bhawana [2 ]
Rawat, Reena [3 ]
Sharma, Prince Prashant [4 ]
Gupta, Piyush [5 ]
机构
[1] SNDT Womens Univ, Dept Analyt Chem, Mumbai 400049, Maharashtra, India
[2] Govt VTYPG Autonomous Coll, Dept Chem, Durg 491001, Chhattisgarh, India
[3] Echelon Inst Technol, Dept Chem, Faridabad 121101, Haryana, India
[4] Gurukul Kangri Deemed Univ, Dept Pharmaceut Sci, Haridwar 249404, India
[5] SRM Inst Sci & Technol, Dept Chem, Delhi 201204, India
关键词
Methotrexate; Nanoparticles; Bioenhancers; Drug delivery; METHOTREXATE;
D O I
10.1016/j.matpr.2021.05.407
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
A simple and practical approach has been successfully explored for the transformation of methotrexate, to its nano form using bioenhancers like piperine and quercetin. The transformed MTX expressed better therapeutic response against cancer in comparison to free MTX. Different techniques have been employed to characterize the synthesized MTX nanoparticle. We utilized X-ray diffractometer (XRD) for determination of crystal properties, UV-Visible (UV-Vis) spectroscopy for optical properties, transmission electron microscopy (TEM) for surface morphology and Zetasizer to examine the average particle size. The observations demonstrated that the average particle size of transformed MTX was found between 24 and 30 nm. We conducted the hemolytic assay as well as cytotoxic tests to examine the biocompatibility of synthesized drug, no prominent inhibition on normal cell growth was observed and cytotoxicity was found in acceptable ranges. (c) 2021 Elsevier Ltd. All rights reserved. Selection and peer-review under responsibility of the scientific committee of the 1st International Conference on Computations in Materials and Applied Engineering - 2021.
引用
收藏
页码:A1 / A7
页数:7
相关论文
共 40 条
  • [1] Exploiting gelatin nanocarriers in the pulmonary delivery of methotrexate for lung cancer therapy
    Abdelrady, Hend
    Hathout, Rania M.
    Osman, Rihab
    Saleem, Imran
    Mortada, Nahed D.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 133 : 115 - 126
  • [2] Amadori D, BREAST CANCER-TOKYO
  • [3] [Anonymous], 2020, GLOBAL CANC REPORTS
  • [4] Arias JL, 2011, MINI-REV MED CHEM, V11, P1
  • [5] Arruebo Manuel, 2011, Cancers (Basel), V3, P3279, DOI 10.3390/cancers3033279
  • [6] Baptista PV, 2012, EXPERT REV MOL DIAGN, V12, P541, DOI [10.1586/erm.12.50, 10.1586/ERM.12.50]
  • [7] Methotrexate-induced pulmonary lymphoma
    Ebeo, CT
    Girish, MR
    Byrd, RP
    Roy, TM
    Mehta, JB
    [J]. CHEST, 2003, 123 (06) : 2150 - 2153
  • [8] FREI E, 1975, NEW ENGL J MED, V292, P846
  • [9] Gold nanoparticles in delivery applications
    Ghosh, Partha
    Han, Gang
    De, Mrinmoy
    Kim, Chae Kyu
    Rotello, Vincent M.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (11) : 1307 - 1315
  • [10] RANDOMIZED STUDY OF HIGH-DOSE VERSUS LOW-DOSE METHOTREXATE IN THE TREATMENT OF EXTENSIVE SMALL CELL LUNG-CANCER
    HANDE, KR
    OLDHAM, RK
    FER, MF
    RICHARDSON, RL
    GRECO, FA
    [J]. AMERICAN JOURNAL OF MEDICINE, 1982, 73 (03) : 413 - 419